Stoke Therapeutics Insider Trades
NASDAQ: STOKHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 45 · $4.66M
- Shares bought / sold
- 0 / 135.38K
- Net activity
- Net selling $4.7 million
Stoke Therapeutics insider activity
Over the last 12 months, Stoke Therapeutics insiders reported 60 transactions on SEC Form 4: 0 open-market purchases and 45 sales. Insiders bought $0 and sold $4.7 million worth of stock, for net insider selling of $4.7 million. The largest seller was Krainer Adrian R., with $1.6 million in reported sales.
The most recent filing shows Allan Jonathan (GENERAL COUNSEL & CORP SEC) selling 627 shares at $26.33 on Oct 2, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put STOK's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
STOK insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Oct 2, 2026 | Allan JonathanGENERAL COUNSEL & CORP SEC | Sale | 627 | $16.51K | Form 4 |
| Oct 1, 2026 | Ticho BarryCHIEF MEDICAL OFFICER | Sale | 1,051 | $27.49K | Form 4 |
| Sep 1, 2026 | Ticho BarryCHIEF MEDICAL OFFICER | Sale | 1,600 | $49.69K | Form 4 |
| Sep 1, 2026 | Ticho BarryCHIEF MEDICAL OFFICER | Sale | 3,945 | $120.37K | Form 4 |
| Aug 18, 2026 | Allan JonathanGENERAL COUNSEL & CORP SEC | Sale | 145 | $4.71K | Form 4 |
| Aug 18, 2026 | Allan JonathanGENERAL COUNSEL & CORP SEC | Sale | 2,716 | $86.93K | Form 4 |
| Aug 18, 2026 | Kaye Edward M. MDDirector | Sale | 637 | $20.68K | Form 4 |
| Aug 18, 2026 | Kaye Edward M. MDDirector | Sale | 11,930 | $381.85K | Form 4 |
| Aug 18, 2026 | Ticho BarryCHIEF MEDICAL OFFICER | Sale | 242 | $7.86K | Form 4 |
| Aug 18, 2026 | Ticho BarryCHIEF MEDICAL OFFICER | Sale | 4,525 | $144.83K | Form 4 |
| Aug 14, 2026 | Allan JonathanGENERAL COUNSEL & CORP SEC | Option exercise | 6,000 | — | Form 4 |
| Aug 14, 2026 | Kaye Edward M. MDDirector | Option exercise | 26,250 | — | Form 4 |
| Aug 14, 2026 | Ticho BarryCHIEF MEDICAL OFFICER | Option exercise | 10,000 | — | Form 4 |
| Aug 3, 2026 | Ticho BarryCHIEF MEDICAL OFFICER | Sale | 1,269 | $37.38K | Form 4 |
| Aug 3, 2026 | Ticho BarryCHIEF MEDICAL OFFICER | Sale | 5,907 | $171.01K | Form 4 |
| Jul 1, 2026 | Ticho BarryCHIEF MEDICAL OFFICER | Sale | 500 | $16.63K | Form 4 |
| Jul 1, 2026 | Ticho BarryCHIEF MEDICAL OFFICER | Sale | 6,728 | $219.43K | Form 4 |
| Jun 16, 2026 | Allan JonathanGENERAL COUNSEL & CORP SEC | Sale | 1,457 | $43.64K | Form 4 |
| Jun 1, 2026 | Ticho BarryCHIEF MEDICAL OFFICER | Sale | 1,795 | $54.89K | Form 4 |
| May 1, 2026 | Ticho BarryCHIEF MEDICAL OFFICER | Sale | 2,243 | $73.55K | Form 4 |
| Apr 1, 2026 | Ticho BarryCHIEF MEDICAL OFFICER | Sale | 1,838 | $60.03K | Form 4 |
| Mar 20, 2026 | Allan JonathanGENERAL COUNSEL & CORP SEC | Sale | 601 | $20.68K | Form 4 |
| Mar 20, 2026 | Allan JonathanGENERAL COUNSEL & CORP SEC | Sale | 8,692 | $292.36K | Form 4 |
| Mar 19, 2026 | Ticho BarryCHIEF MEDICAL OFFICER | Sale | 1,461 | $43.82K | Form 4 |
| Mar 19, 2026 | Ticho BarryCHIEF MEDICAL OFFICER | Option exercise | 1,365 | $2.99K | Form 4 |
| Mar 18, 2026 | Allan JonathanGENERAL COUNSEL & CORP SEC | Sale | 72 | $2.37K | Form 4 |
| Mar 18, 2026 | Allan JonathanGENERAL COUNSEL & CORP SEC | Sale | 334 | $10.62K | Form 4 |
| Mar 18, 2026 | Allan JonathanGENERAL COUNSEL & CORP SEC | Sale | 4,222 | $132.08K | Form 4 |
| Mar 18, 2026 | Hoitt JasonChief Patient Officer | Sale | 30 | $985.50 | Form 4 |
| Mar 18, 2026 | Hoitt JasonChief Patient Officer | Sale | 139 | $4.42K | Form 4 |
| Mar 18, 2026 | Hoitt JasonChief Patient Officer | Sale | 1,762 | $55.12K | Form 4 |
| Mar 18, 2026 | Leggett ThomasChief Financial Officer | Sale | 37 | $1.22K | Form 4 |
| Mar 18, 2026 | Leggett ThomasChief Financial Officer | Sale | 172 | $5.47K | Form 4 |
| Mar 18, 2026 | Leggett ThomasChief Financial Officer | Sale | 2,173 | $67.98K | Form 4 |
| Mar 18, 2026 | Ticho BarryCHIEF MEDICAL OFFICER | Sale | 103 | $3.38K | Form 4 |
| Mar 18, 2026 | Ticho BarryCHIEF MEDICAL OFFICER | Sale | 483 | $15.35K | Form 4 |
| Mar 18, 2026 | Ticho BarryCHIEF MEDICAL OFFICER | Sale | 6,100 | $190.83K | Form 4 |
| Mar 17, 2026 | Allan JonathanGENERAL COUNSEL & CORP SEC | Sale | 1,791 | $59.78K | Form 4 |
| Mar 17, 2026 | Allan JonathanGENERAL COUNSEL & CORP SEC | Sale | 2,476 | $81.06K | Form 4 |
| Mar 17, 2026 | Hoitt JasonChief Patient Officer | Sale | 748 | $24.96K | Form 4 |
| Mar 17, 2026 | Hoitt JasonChief Patient Officer | Sale | 1,033 | $33.82K | Form 4 |
| Mar 17, 2026 | Leggett ThomasChief Financial Officer | Sale | 922 | $30.77K | Form 4 |
| Mar 17, 2026 | Leggett ThomasChief Financial Officer | Sale | 1,274 | $41.71K | Form 4 |
| Mar 17, 2026 | Ticho BarryCHIEF MEDICAL OFFICER | Sale | 2,587 | $86.34K | Form 4 |
| Mar 17, 2026 | Ticho BarryCHIEF MEDICAL OFFICER | Sale | 3,577 | $117.11K | Form 4 |
| Mar 15, 2026 | Allan JonathanGENERAL COUNSEL & CORP SEC | Option exercise | 12,000 | — | Form 4 |
| Mar 15, 2026 | Allan JonathanGENERAL COUNSEL & CORP SEC | Option exercise | 6,000 | — | Form 4 |
| Mar 15, 2026 | Allan JonathanGENERAL COUNSEL & CORP SEC | Option exercise | 7,475 | — | Form 4 |
| Mar 15, 2026 | Kaye Edward M. MDDirector | Option exercise | 26,250 | — | Form 4 |
| Mar 15, 2026 | Kaye Edward M. MDDirector | Option exercise | 35,500 | — | Form 4 |
| Mar 15, 2026 | Ticho BarryCHIEF MEDICAL OFFICER | Option exercise | 10,750 | — | Form 4 |
| Mar 15, 2026 | Ticho BarryCHIEF MEDICAL OFFICER | Option exercise | 10,000 | — | Form 4 |
| Mar 15, 2026 | Ticho BarryCHIEF MEDICAL OFFICER | Option exercise | 13,100 | — | Form 4 |
| Mar 15, 2026 | Hoitt JasonChief Patient Officer | Option exercise | 10,000 | — | Form 4 |
| Mar 15, 2026 | Leggett ThomasChief Financial Officer | Option exercise | 14,750 | — | Form 4 |
| Mar 13, 2026 | LEVIN ARTHUR ADirector | Sale | 605 | $22.26K | Form 4 |
| Mar 10, 2026 | Krainer Adrian R.Director | Sale | 33,243 | $1.32M | Form 4 |
| Mar 10, 2026 | TZIANABOS ARTHURInterim Executive Chair | Sale | 4,355 | $174.21K | Form 4 |
| Mar 10, 2026 | TZIANABOS ARTHURInterim Executive Chair | Option exercise | 3,955 | $32.95K | Form 4 |
| Mar 2, 2026 | Krainer Adrian R.Director | Sale | 7,229 | $286.72K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4